NIDCOM Hails NAFTraPh Community Health Awareness Project
As part of giving back to the society, the Nigerian Association of Foreign Trained Pharmacists ( NAFTraPh) seeks partnership with Nigerians in Diaspora Commission (NiDCOM) in creating health awareness to communities in the Country.
Gabriel Odu in a statement on Friday said Hon.Abike Dabiri-Erewa, Chairman/ CEO, Nigerians in Diaspora Commission is pleased with the noble gesture of the group in going down to the grassroots to give back to the Communities on how to tackle their health challenges.
The NiDCOM Boss promised to synergise with the NAFTraPh to ensure that the awareness is done all over the length and breath of country.
She, however, said these will be facilitated with the States Diaspora Focal Point Officers in their various localities.
The NiDCOM Boss further encouraged the association to key into the various policies and programmes of the commission which include among others, the Nigerian Diaspora Investment Trust Fund recently approved by President Muhammadu Buhari, the Diaspora Investment summit etc and tap into the potentials and opportunities there from.
She added that the energy and zeal the Association has shown in giving back to the society is most commendable.
Dr. John Ejezie, President of the Association aims to promote volunteerism that will push the Country to the next level through social health awareness.
This he believes, the Association can achieve through health education in the areas of vacination, Immunization and screening health fairs that will be organized in different Communities.
The Association also engages in training Pharmacists on immunization and the first batch was done last year with the American Pharmacists Association programme.
The Nigerian Association of Foreign Trained Pharmacists (NAFTraPh) is a pharmaceutical non-profit organisation that helps people in Nigeria with their pharmaceutical distribution system. They help hospitals integrate the services of clinical pharmacists and also educate the general Community on the use of pharmaceutical products to optimize their health prospects.
